Evaluation of soluble platelet cell adhesion molecule sPECAM-1 and chemokine MCP-1 (CCL2) concentration in CSF of patients with tick-borne encephalitis;Badanie stȩżenia rozpuszczonej cza̧steczki adhezyjnej sPECAM-1 oraz chemokiny MCP-1 w płynie mózgowo-rdzeniowym u chorych na kleszczowe zapalenie mozgu

Polski Merkuriusz Lekarski

Volumn 20, Issue 115, 2006, Pages 46-48

  Michałowska Wender, Grazyna ^a,b   Losy, Jacek ^a,b   Kondrusik, Maciej ^c   Zajkowska, Joanna ^c   Pancewicz, Sławomir ^c   Grygorczuk, Sambor ^c   Wender, Mieczysław ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adhesion molecule sPECAM 1; Cerebrospinal fluid; Chemokine MCP 1; Tick borne encephalitis

Indexed keywords

BETA CHEMOKINE; CD31 ANTIGEN; GLYCOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; MONOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FAMILY; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; TICK BORNE ENCEPHALITIS; CEREBROSPINAL FLUID; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD31; CHEMOKINE CCL2; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 31944445899     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Becker K.: Targeting the central nervous system inflammatory response in ischemic stroke. Curr. Opin. Neurol., 2001, 14, 349-353.
2. Berilaeque M.: Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 1993, 11, 767-781.
3. Carr M., Rath S., Luther E.: Monocyte Chemoattractant protein 1 acts a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA, 1994, 91, 3652-3658.
4. Goldberger A., Middleton K., Oliver J. i wsp.: Biosynhesis and processing of the V cell adhesion molecule PECAM-1 includes productions of soluble form. J. Biol. Chem., 1994, 269, 17183-17191.
5. Gunthar G.: Tick-borne encephalitis on pathogenesis and prognosis. Thesis Karolinska Institutet, 1997.
6. Gunthar G., Hagland M., Lindquist L. i wsp.: Intrathecal production of neopterin and beta 2 microglobuline in thick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology. Scand. J. Infect. Dis., 1996, 28, 131-138.
7. Haglund M., Gunthar G.: Tick-borne encephalitis- pathogenesis, clinical course and long-term follow-up. Vaccine, 2003, 21, S1, 11-18.
8. Kondrusik M., Hermanowska-Szpakowicz T., Jaroszewicz E.: Stȩżenie czynnika martwicy nowotworu alfa i interteukiny 1 beta płynu mózgowordzeniowego w przebiegu kleszczowego zapalenia mózgu. Pol. Merk. Lek., 1998, 4, 21, 126-129.
9. Kondrusik M., Pancewicz S., Zajkowska J. i wsp.: Stȩżenie czynnika martwicy nowotworu alfa i interteukiny 1 beta w surowicy chorych na kleszczowe zapalenie mózgu. Pol. Merk. Lek., 2001, 61, 26-27.
10. Losy J., Niezgoda A., Wender M.: Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J. Neuroimmunol., 1999, 99, 169-172.
11. Losy J., Michałowska-Wender G., Wender M.: Chemokiny MIP-1α oraz MCP-1 u pacjentów ze stwardnieniem rozsianym leczonych interferonem beta 1a. Neur. Neurochir. Pol., 2001, 35, 583-588.
12. Losy J., Zaremba J.: Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke, 2001, 32, 2695-2696.
13. Mahad D., Howell S., Woodroofe M.: Expression of chemokine in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psych., 2002, 72, 498-502.
14. Michałowska-Wender G., Losy J., Wender M.: Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patients. Folia Neuopathol., 2001, 39, 1-5.
15. Newman P.: The biology of PECAM-1. J. Clin. Invest., 1997, 100, 25-29.
16. Pancewicz S., Hermanowska-Szpakowicz T., Makarewicz-Płońska M. i wsp.: Obniżenie mechanizmów obrony antyoksydacyjnej w płynie mózgowo-rdzeniowym u chorych z kleszczowym zapaleniem mozgu. Neurol. Neurochir. Pol., 2002, 36, 767-770.
17. Ramshoff R., Tani M.: Do chemokines mediate leukocyte recruitment in post traumatic CNS inflammation TIMNS. 1998, 21, 154-160.
18. Simpson J., Newcombe J., Uzner M.: Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol., 1998, 84, 238-242.
19. Sindern E., Niederkinhaus Y., Henschel M. i wsp.: Differential relaese of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis. Acta. Neurol. Scand., 2001, 104, 88-91.
20. Vila N., Castillo J., Divalos A. i wsp.: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke, 2000, 31, 2325-2329.
21. Zaremba J., Losy J.: sPECAM-1 in serum and CSF of acute ischemic stroke patients. Acta. Neurol. Scand., 2002, 106, 292-298.